What is the evidence for a role for diet and nutrition in osteoarthritis?

Sally Thomas, Heather Browne, Ali Mobasheri, Margaret P. Rayman•View original
HighlightsAccessiblefable voice
Osteoarthritis affects roughly 18 percent of women and nearly 10 percent of men over 60, and a quarter of those people cannot perform basic daily activities. Treatment options are thin, mostly focusing on symptom management or, when things get severe, joint replacement. That gap is exactly why Thomas, Browne, Mobasheri, and Rayman looked into diet. Can what you eat actually change how your joints feel? The honest answer is, sometimes yes, sometimes maybe, and sometimes the evidence just isn't there yet. The strongest case belongs to weight loss. Excess body fat damages joints in two ways simultaneously. The obvious one is mechanical; more mass means more force on your knees and hips. The less obvious one is chemical. Fat tissue releases signaling molecules called adipokines that drive inflammation and cartilage breakdown. In the Research on Osteoarthritis Against Disability cohort, people with multiple metabolic syndrome components had an odds ratio of nearly ten for developing knee osteoarthritis. The good news is that the relationship runs both ways. A meta-analysis of randomized controlled trials showed meaningful improvements once weight loss exceeded 5 percent, and a 10 percent reduction was linked to less pain and better function. Diet combined with exercise produced the best results, and the dose-response relationship was statistically clear. The next tier involves dietary fats. Osteoarthritic joints accumulate omega-6 fatty acids, which are precursors to pro-inflammatory compounds. Omega-3 fatty acids from oily fish, specifically eicosapentaenoic acid and docosahexaenoic acid, generate less inflammatory signaling and produce anti-inflammatory compounds called resolvins. Baker and colleagues found that higher total plasma omega-3s and docosahexaenoic acid were inversely associated with cartilage loss measured by magnetic resonance imaging. Clinical trials have been mixed; a meta-analysis of five trials found no significant effect on pain overall. However, Hill and colleagues found greater benefit at a low dose of around 0.45 grams than at a high one, and the review points to roughly 1.5 grams per day as a potentially useful target. Cholesterol tells a related story. In the Chingford study, raised serum cholesterol roughly doubled osteoarthritis risk, and statin use was associated with a 57 percent lower progression seen on radiographs. Dietary changes including plant stanols and sterols at 2 grams per day can reduce low-density lipoprotein cholesterol by around 10 percent, which may matter here. Vitamin K has a coherent biological mechanism; it activates proteins in bone and cartilage that regulate mineralization. Observational studies link low plasma vitamin K to the onset of osteoarthritis and to cartilage and meniscal damage. The one randomized trial found no overall benefit, but in participants who actually became vitamin K sufficient, joint-space narrowing was 47 percent less. Vitamin D serves as the cautionary tale. Low levels associate with osteoarthritis observationally, but three large randomized trials found no significant effect on cartilage volume or pain. The review's explanation is that low vitamin D may reflect poor overall health rather than cause joint disease. Clinicians should check vitamin D status and aim for at least 50 nanomoles per liter, but supplementing beyond sufficiency hasn't shown any significant impact in trials. The hierarchy is clear. Weight loss with exercise has the firmest footing. Shifting toward omega-3s and lowering cholesterol comes next. Ensuring adequate vitamin K is plausible and low-risk. Vitamin D supplementation, beyond correcting deficiency, remains unproven for joint health. Most of this evidence is observational and concentrated on knee osteoarthritis, and well-designed trials are still needed. However, these changes align with general healthy eating guidance, which means the risk of trying them is low and the potential upside is real.

Osteoarthritis affects roughly 18 percent of women and nearly 10 percent of men over 60, and a quarter of those people cannot perform basic daily activities. Treatment options are thin, mostly focusing on symptom management or, when things get severe, joint replacement. That gap is exactly why Thomas, Browne, Mobasheri, and Rayman looked into diet.

Can what you eat actually change how your joints feel? The honest answer is, sometimes yes, sometimes maybe, and sometimes the evidence just isn't there yet.

The strongest case belongs to weight loss. Excess body fat damages joints in two ways simultaneously. The obvious one is mechanical; more mass means more force on your knees and hips.

The less obvious one is chemical. Fat tissue releases signaling molecules called adipokines that drive inflammation and cartilage breakdown. In the Research on Osteoarthritis Against Disability cohort, people with multiple metabolic syndrome components had an odds ratio of nearly ten for developing knee osteoarthritis.

The good news is that the relationship runs both ways. A meta-analysis of randomized controlled trials showed meaningful improvements once weight loss exceeded 5 percent, and a 10 percent reduction was linked to less pain and better function. Diet combined with exercise produced the best results, and the dose-response relationship was statistically clear.

The next tier involves dietary fats. Osteoarthritic joints accumulate omega-6 fatty acids, which are precursors to pro-inflammatory compounds. Omega-3 fatty acids from oily fish, specifically eicosapentaenoic acid and docosahexaenoic acid, generate less inflammatory signaling and produce anti-inflammatory compounds called resolvins.

Baker and colleagues found that higher total plasma omega-3s and docosahexaenoic acid were inversely associated with cartilage loss measured by magnetic resonance imaging. Clinical trials have been mixed; a meta-analysis of five trials found no significant effect on pain overall. However, Hill and colleagues found greater benefit at a low dose of around 0.45 grams than at a high one, and the review points to roughly 1.5 grams per day as a potentially useful target.

Cholesterol tells a related story. In the Chingford study, raised serum cholesterol roughly doubled osteoarthritis risk, and statin use was associated with a 57 percent lower progression seen on radiographs. Dietary changes including plant stanols and sterols at 2 grams per day can reduce low-density lipoprotein cholesterol by around 10 percent, which may matter here.

Vitamin K has a coherent biological mechanism; it activates proteins in bone and cartilage that regulate mineralization. Observational studies link low plasma vitamin K to the onset of osteoarthritis and to cartilage and meniscal damage. The one randomized trial found no overall benefit, but in participants who actually became vitamin K sufficient, joint-space narrowing was 47 percent less.

Vitamin D serves as the cautionary tale. Low levels associate with osteoarthritis observationally, but three large randomized trials found no significant effect on cartilage volume or pain. The review's explanation is that low vitamin D may reflect poor overall health rather than cause joint disease.

Clinicians should check vitamin D status and aim for at least 50 nanomoles per liter, but supplementing beyond sufficiency hasn't shown any significant impact in trials.

The hierarchy is clear. Weight loss with exercise has the firmest footing. Shifting toward omega-3s and lowering cholesterol comes next.

Ensuring adequate vitamin K is plausible and low-risk. Vitamin D supplementation, beyond correcting deficiency, remains unproven for joint health. Most of this evidence is observational and concentrated on knee osteoarthritis, and well-designed trials are still needed.

However, these changes align with general healthy eating guidance, which means the risk of trying them is low and the potential upside is real.